Common Off-Label Uses Polycystic Ovary Syndrome (PCOS) Some providers prescribe GLP-1s to improve insulin resistance, weight-related symptoms, and menstrual regularity Small studies show potential benefits Infertility / Preconception Support Off-label use in people trying to conceive (especially those with an elevated BMI and/or insulin resistance)
In Phase 2 clinical trials, 88.8% of patients successfully tolerated treatment through 48 weeks
Some have been found to also protect the heart, and can benefit people at risk for a heart attack
Another oral GLP-1 option is being tested and may become available in the future
Its clinical trial participants lost an average of 20% of their body weight within a year and a half of starting treatment
Como consecuencia, se desarrollan una serie de comorbilidades estrechamente ligadas a la obesidad, tales como la apnea obstructiva del sueo (AOS), la enfermedad heptica metablica, la nefropata por obesidad y ciertas afecciones dermatolgicas, entre otras